NBTXR3, Radiation Therapy, and Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Cancer
Phase 2 Terminated
14 enrolled
Avelumab and Radiation in Muscle-Invasive Bladder Cancer
Phase 2 Terminated
14 enrolled 14 charts
IRRADIATE-Lung
Phase 2 Terminated
19 enrolled 11 charts
IMMUNOSABR2
Phase 2 Terminated
88 enrolled
Neutron Radiation Therapy and Pembrolizumab in Treating Participants With Advanced Urothelial Carcinoma
Phase 2 Terminated
12 enrolled 10 charts
TARA
Phase 2 Terminated
1 enrolled 11 charts
Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer
Phase 2 Terminated
11 enrolled 11 charts
Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer
Phase 2 Terminated
10 enrolled 7 charts
Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site
Phase 2 Terminated
1 enrolled 9 charts
Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)
Phase 2 Terminated
18 enrolled
ThoRaT
Phase 2 Terminated
118 enrolled
LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer
Phase 2 Terminated
3 enrolled 11 charts
Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma
Phase 2 Terminated
4 enrolled 9 charts
Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)
Phase 2 Terminated
53 enrolled 12 charts
HALO-IST
Phase 2 Terminated
4 enrolled
RadEr
Phase 2 Terminated
25 enrolled
Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
Phase 2 Terminated
13 enrolled 9 charts
Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy
Phase 2 Terminated
1 enrolled 5 charts
ADAPT
Phase 2 Terminated
27 enrolled 10 charts
Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
Phase 2 Terminated
4 enrolled 4 charts
Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.
Phase 2 Terminated
16 enrolled 19 charts
Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer
Phase 2 Terminated
6 enrolled 9 charts
T-Cell Depleted Double UCB for Refractory AML
Phase 2 Terminated
3 enrolled 9 charts
Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia
Phase 2 Terminated
22 enrolled
Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer
Phase 2 Terminated
28 enrolled 9 charts
Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery
Phase 2 Terminated
1 enrolled 4 charts
Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer
Phase 2 Terminated
7 enrolled 8 charts
Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma
Phase 2 Terminated
62 enrolled 8 charts
Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy
Phase 2 Terminated
17 enrolled 7 charts
Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma
Phase 2 Terminated
28 enrolled 9 charts
Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia
Phase 2 Terminated
22 enrolled 11 charts
Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC
Phase 2 Terminated
13 enrolled 9 charts
Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy
Phase 2 Terminated
18 enrolled 8 charts
Radiation Therapy With Capecitabine in Rectal Cancer
Phase 2 Terminated
30 enrolled